NASDAQ: $ACRS New Hope for Lichen Planus Patients There is promising news for individuals struggling with the chronic skin condition lichen planus. Aclaris Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to their investigational drug, modzatinib (ATI-2138), for the treatment of moderate to severe cases of this…